FDA NDC Directory · JSON-LD · Markdown

Floxuridine

NDC 81643-9270 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Labeler / ManufacturerJND Therapeutics, Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA075387
Dosage form / routeINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · INTRA-ARTERIAL
Active ingredientsFLOXURIDINE (500 mg/1)
Marketing started20220609
Package count1

External sources

Source: openFDA. Public-domain (CC0).